Kind Minds Program for Youth With Anxiety and Depression
Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Apr 25, 2022
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
The Kind Minds Program is a clinical trial designed to help teenagers aged 12 to 17 who are struggling with anxiety and depression. The study is exploring whether having both the teenager and their parent or caregiver learn mindfulness techniques together can provide extra benefits for the teen's mental health. Mindfulness involves practices that help individuals focus on the present moment, which has been shown to reduce feelings of anxiety and depression. In this 9-week program, some parents or caregivers will join their teens in the mindfulness training, while others will not, allowing researchers to compare the outcomes for both groups.
To participate, families need to meet certain criteria: the teenager must have a current diagnosis of anxiety or depression, and they must have a parent or caregiver willing to join the program. Both the teen and the parent need to be comfortable using a smartphone and able to communicate in English. Throughout the study, participants will complete questionnaires about their moods and mental health at the beginning, middle, and end of the program, which will take about 12 weeks in total. This trial offers a unique opportunity to see how practicing mindfulness together might improve the mental well-being of both teens and their caregivers.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Participants will include:
- • 1. one adolescent (aged 12-17 years) with a current diagnosis of an anxiety or depressive disorder)
- • 2. one of their parents/caregivers.
- • 3. Both adolescent and caregiver must speak English to the degree necessary to participate in the intervention program, which is only available in English.
- • 4. Parent and youth must have a smart phone and be willing to download the online mindfulness program.
- Exclusion Criteria:
- * Exclusion criteria apply to both caregiver and adolescent and include:
- • 1. current alcohol or substance use disorder or suicidality
- • 2. lifetime diagnosis of bipolar disorder, schizophrenia, autism, conduct disorder, or developmental delay diagnosed by an independent evaluator;
- • 3. English reading level below 4th grade
- • 4. non English speaking
- • 5. currently receiving mindfulness-based mental health services or taking medication to treat anxiety or depression.
About University Of California, Los Angeles
The University of California, Los Angeles (UCLA) is a prestigious academic institution renowned for its commitment to research and innovation in the biomedical field. As a clinical trial sponsor, UCLA leverages its cutting-edge facilities, expert faculty, and collaborative environment to advance medical knowledge and improve patient care. The university is dedicated to conducting rigorous clinical research that adheres to the highest ethical standards, aiming to translate scientific discoveries into effective therapies and interventions. Through its diverse array of clinical trials, UCLA seeks to address critical health challenges while fostering the development of future healthcare leaders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Imperial, California, United States
Patients applied
Trial Officials
Denise A Chavira, PhD
Principal Investigator
University of California, Los Angeles
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials